Clinical Trial Update: A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) [Phase 3]

View source ↗

Summary

Phase 3 double-blind, placebo-controlled trial evaluating Levetiracetam in epilepsy patients with generalized tonic-clonic seizures has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsy, Generalized Tonic-Clonic Seizures | Phase 3 | Status: COMPLETED | Results posted: 2015-05-13